# ELICIO THERAPEUTICS INC (ELTX)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/ELTX/

- Reporting holders: 3
- Reported value: $2.3M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [SHAH CAPITAL MANAGEMENT](https://holderbook.com/funds/1383838-shah-capital-management/) | $2.3M | 1,250,000 | 0.4% | 1 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $4.0K | 2,178 | 0.0% | 5 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $1.8K | 1,013 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $2.3M |
| Q2 2026 | 59 | $30.2M |
| Q1 2026 | 49 | $34.2M |
| Q4 2025 | 40 | $19.4M |
| Q3 2025 | 31 | $22.5M |
| Q2 2025 | 25 | $12.2M |
| Q1 2025 | 24 | $9.8M |
| Q4 2024 | 17 | $2.3M |
| Q3 2024 | 18 | $2.5M |
| Q2 2024 | 19 | $2.7M |
| Q1 2024 | 18 | $3.1M |
| Q4 2023 | 18 | $2.8M |